Sign in: Staff/Students
Professor Weeks and his team
The University of Liverpool has been awarded £850,000 from the National Institute for Health Research (NIHR) to further develop an award-winning device that could save the lives of women all over the world.
Professor of International Maternal Health, Andrew Weeks from the Institute of Translational Medicine received the funds from NIHR’s Innovation for Innovation programme (i4i) for the Postpartum Haemorrhage (PPH) Butterfly.
PPH is often defined as the loss of more than 500ml or 1,000ml of blood within the first 24 hours following childbirth. It is a common maternity emergency affecting 40,000 British women each year. Although it can usually be treated in the UK, many suffer long-lasting complications.
Major cause of death
Globally, however, it remains a major cause of death and is responsible for around 25% of the 289,000 maternal deaths annually. Although common, its management has changed little over the last 30 years. But now Professor Weeks has developed the PPH Butterfly, a device that not only stops the bleeding immediately, but also helps to diagnose its source.
Professor Weeks’ collaboration with the University’s Department of Medical Physics and Clinical Engineering, Royal Liverpool and Broadgreen Universities Hospital NHS Trust, Liverpool Business Gateway units, Protolabs, Plastribution and Pelican Feminine Health Care, led to the Research Innovation Award in the NIHR NW Research and Innovations awards in 2015. They were also shortlisted for the prestigious Plastics Industry Award in 2015.
The first clinical trials of the device have now been successfully completed. The next phase will see the device tested this summer on women identified as suffering from PPH.
Professor Weeks, who is also a consultant obstetrician at the Liverpool Women’s Hospital, said: “This funding is vital in helping us to take the development of this device forward. It is also a testament to strong partnership working with the University, the NHS and Industry partners.
“Going forward we are currently developing a training package for those who will be using it with view to the clinical trials this summer.”
A paper regarding the development on the device, entitled ‘PPH Butterfly: a novel device to treat postpartum haemorrhage through uterine compression’, has been published in British Medical Journal Innovations and can be found here.
A video about the device can be seen here.
You must be logged in to post a comment.
All recent news
Winter break: How to travel safety
Liverpool academics named in global list of influential researchers
Liverpool invests in immunology cancer research
Insider Imprint student journal launches new podcast series
Event today: Brexit Information for EU Students
1/ Today, we are launching the latest COVID-19 Policy Brief with @LpoolCityRegion, a paper by Prof Simeon Yates, Associate PVC @LivUni, "COVID-19 & Digital Exclusion: Insights & Implications for the Liverpool City Region" https://bit.ly/2UGIfIZ
WE’RE LIVE! 💰
Join @KieranMaguire and @introspective81 for a tell-all talk on finance in the modern game.
If you’re after no-nonsense takes on Project Big Picture, European breakaways and club ownership, this one’s definitely for you.
STREAMING NOW: https://youtu.be/DwAf9e2_bew
World-leading experimental cancer researcher Professor Christian Ottensmeier has joined Liverpool to lead a major new programme of cutting-edge #immunology #cancer research in collaboration with local #NHS partners.
Full story ➡️ https://bit.ly/2V1tpga